NorcoTirzepatide
Ordered Tirzepatide from Norco? Mail in a sample (US only) and let us test it.
Test my supplyNorco's Tirzepatide record is mixed: an early lot tested at 74.5% purity and -48% fill, followed by two 99.9% purity passes with moderate underfill. The improving streak helps, but the evidence base is still small.
Unlock original COAs
View and download original lab PDFs for Finnrick tests, including Norco rows.
Cancel anytime
| Date | Result | Test | Lab | Purity | Dosage | Label | COA |
|---|---|---|---|---|---|---|---|
| 23 Oct 2026 | Pass | u9mdnwz Tested | lab name | View COA | |||
| 7 Sep 2026 | Pass | jbpqvkm Tested | lab name | View COA | |||
| 27 Aug 2026 | Fail | ue7dvhk Tested | lab name | View COA | |||
About Norco test results from Finnrick
Norco is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 4 peptides and 21 tests, including ratings, observed price signals, recent test dates, and correction history where available.
Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.
The most visible Norco peptides in this dataset are BPC-157 (4 tests), GHK-Cu (2 tests) and Retatrutide (12 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.
Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 21 recent tests.
Ordered Tirzepatide from Norco? Mail in a sample (US only) and let us test it.
Test my supply